Literature DB >> 17988658

Reproducibility of blood tests of liver fibrosis in clinical practice.

Paul Calès1, Pascal Veillon, Anselme Konaté, Elisabeth Mathieu, Catherine Ternisien, Alain Chevailler, Alban Godon, Yves Gallois, Françoise Joubaud, Isabelle Hubert-Fouchard, Frédéric Oberti, Stéphane Réaud, Gilles Hunault, Françoise Mauriat, Françoise Lunel-Fabiani.   

Abstract

OBJECTIVES: To evaluate the inter-laboratory reproducibility of blood test for liver fibrosis: FibroMeter, Fibrotest, APRI and their composites variables. DESIGN AND METHODS: Four studies, including 147 patients, were performed: study #1 included 2 metachronous blood samples and 2 laboratories; studies #2, #3 and #4 included synchronous samples with assays delayed at day 1 in 12 laboratories, at day 0 in 10 laboratories and at day 0 or 1 in 2 laboratories, respectively. Agreement was evaluated by the intraclass correlation coefficient (r(ic)).
RESULTS: In studies #1, #2 and #4, r(ic) for FibroMeter was 0.893, 0.942 and 0.991, respectively. In study #3, the r(ic) were: FibroMeter: 0.963, Fibrotest: 0.984, APRI: 0.949. Large simulated variations in composite variables had a weak impact on FibroMeter.
CONCLUSIONS: When blood marker limits are controlled, inter-laboratory agreement of blood tests is excellent in clinical practice conditions. Blood tests are robust against the variability of composite blood variables.

Entities:  

Mesh:

Year:  2007        PMID: 17988658     DOI: 10.1016/j.clinbiochem.2007.08.009

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  12 in total

Review 1.  Liver elastography, comments on EFSUMB elastography guidelines 2013.

Authors:  Xin-Wu Cui; Mireen Friedrich-Rust; Chiara De Molo; Andre Ignee; Dagmar Schreiber-Dietrich; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

2.  Non-invasive assessment of liver fibrosis in chronic hepatitis C.

Authors:  Laurent Castera
Journal:  Hepatol Int       Date:  2011-01-20       Impact factor: 6.047

3.  Non-invasive assessment for alpha-1 antitrypsin deficiency-associated liver disease: new insights on steatosis and fibrosis in Pi*ZZ carriers.

Authors:  Siyer Roohani; Frank Tacke
Journal:  Transl Gastroenterol Hepatol       Date:  2019-12-12

4.  Use of serum biomarkers in staging of canine hepatic fibrosis.

Authors:  Maud Menard; Alexis Lecoindre; Jean-Luc Cadoré; Michèle Chevallier; Aurélie Pagnon; Juan Hernandez; Rodolpho Oliveira Leal; Marine Hugonnard; Véronique Miette; Marie Destro; Benoît Rannou; Ghita Benchekroun; Patrick Lecoindre
Journal:  J Vet Diagn Invest       Date:  2019-07-26       Impact factor: 1.279

5.  Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B.

Authors:  Yong-Peng Chen; Jie Peng; Jin-Lin Hou
Journal:  Hepatol Int       Date:  2013-05-17       Impact factor: 6.047

6.  Development and validation of a neural network for NAFLD diagnosis.

Authors:  Paolo Sorino; Angelo Campanella; Caterina Bonfiglio; Antonella Mirizzi; Isabella Franco; Antonella Bianco; Maria Gabriella Caruso; Giovanni Misciagna; Laura R Aballay; Claudia Buongiorno; Rosalba Liuzzi; Anna Maria Cisternino; Maria Notarnicola; Marisa Chiloiro; Francesca Fallucchi; Giovanni Pascoschi; Alberto Rubén Osella
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

Review 7.  Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Authors:  Sangheun Lee; Do Young Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 8.  Non-invasive assessment of liver fibrosis.

Authors:  Vasilios Papastergiou; Emmanuel Tsochatzis; Andrew K Burroughs
Journal:  Ann Gastroenterol       Date:  2012

9.  Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B.

Authors:  Yu-rui Liu; Bin-bin Lin; Da-wu Zeng; Yue-yong Zhu; Jing Chen; Qi Zheng; Jing Dong; Jia-ji Jiang
Journal:  BMC Gastroenterol       Date:  2014-08-16       Impact factor: 3.067

10.  Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C.

Authors:  Paul Calès; Victor de Ledinghen; Philippe Halfon; Yannick Bacq; Vincent Leroy; Jérôme Boursier; Juliette Foucher; Marc Bourlière; Anne de Muret; Nathalie Sturm; Gilles Hunault; Frédéric Oberti
Journal:  Liver Int       Date:  2008-05-19       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.